| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 87.90B | 94.34B | 99.73B | 99.73B | 85.16B | 87.10B |
| Gross Profit | 8.49B | 10.09B | 9.16B | 6.05B | 6.47B | 5.85B |
| EBITDA | 5.32B | 3.40B | 2.97B | 2.09B | 3.44B | 3.09B |
| Net Income | 2.03B | 2.08B | -70.00M | -2.05B | -1.21B | -3.08B |
Balance Sheet | ||||||
| Total Assets | 77.81B | 78.33B | 81.18B | 82.90B | 80.16B | 82.28B |
| Cash, Cash Equivalents and Short-Term Investments | 15.70B | 15.23B | 12.29B | 17.28B | 19.71B | 20.07B |
| Total Debt | 2.42B | 2.92B | 6.86B | 9.95B | 8.62B | 8.86B |
| Total Liabilities | 23.43B | 25.29B | 29.91B | 34.01B | 30.38B | 32.68B |
| Stockholders Equity | 54.02B | 52.70B | 50.85B | 48.51B | 49.44B | 49.27B |
Cash Flow | ||||||
| Free Cash Flow | -755.00M | 690.00M | -963.00M | -2.43B | -411.00M | 462.00M |
| Operating Cash Flow | 2.46B | 2.77B | 958.00M | -787.00M | 3.50B | 3.04B |
| Investing Cash Flow | -1.51B | 4.50B | -1.21B | -2.05B | -3.46B | -2.72B |
| Financing Cash Flow | -1.32B | -4.99B | -5.00B | -30.00M | -1.33B | 4.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥46.39B | 7.97 | 8.46% | 2.64% | -6.35% | 18.49% | |
78 Outperform | ¥284.51B | 8.56 | 6.37% | 2.88% | 4.86% | 10.95% | |
76 Outperform | ¥706.48B | 14.05 | 7.20% | 2.41% | -0.73% | 88.36% | |
75 Outperform | ¥487.78B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
71 Outperform | ¥18.75B | 8.04 | ― | 2.70% | -8.63% | -55.68% | |
70 Outperform | ¥56.34B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |